Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
0.32 CAD | 0.00% | -5.88% | +48.84% |
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cannabidiol-integrated Pharmaceuticals
100.0
%
| 0 | 100.0 % | 3 | 100.0 % | +1,255.72% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
94.5
%
| 0 | 17.3 % | 3 | 94.5 % | +7,281.67% |
United Kingdom
3.2
%
| - | - | 0 | 3.2 % | - |
Rest of the World
2.3
%
| 0 | 20.9 % | 0 | 2.3 % | +49.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nir Avram
FOU | Founder | 70 | - |
Founder | - | 2018 | |
Yoram Drucker
FOU | Founder | 58 | 2018 |
Nelson Halpern
DFI | Director of Finance/CFO | - | - |
Roni Kamhi
COO | Chief Operating Officer | - | 2022 |
Eyal Flom
BRD | Director/Board Member | 58 | 2019 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yoram Drucker
FOU | Founder | 58 | 2018 |
Peter Bloch
BRD | Director/Board Member | 63 | 2020 |
Chairman | 59 | 2014 | |
Founder | - | 2018 | |
Eyal Flom
BRD | Director/Board Member | 58 | 2019 |
Ralph Bossino
BRD | Director/Board Member | - | 2019 |
Director/Board Member | 36 | 2019 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 252,044,052 | 210,103,934 ( 83.36 %) | 0 | 83.36 % |
Company contact information
InnoCan Pharma Corp.
525-8th Avenue SW Suite 2400
T2P 1G1, Calgary
+403-777-1519
http://www.innocanpharma.com
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+48.84% | 64 M $ | |
+59.64% | 525 B $ | |
-10.34% | 381 B $ | |
-6.75% | 262 B $ | |
-11.26% | 253 B $ | |
-16.04% | 221 B $ | |
+2.58% | 202 B $ | |
-9.00% | 200 B $ | |
-43.58% | 163 B $ | |
+3.74% | 146 B $ |
- Stock
- Equities
- Stock InnoCan Pharma Corporation - Canadian Securities Exchange
- Company InnoCan Pharma Corporation